Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Plex Pharmaceuticals Logo
Plex Pharmaceuticals Growth Score
57
CB Rank
123154
Heat Score
47
Plex Pharmaceuticals a biotechnology company aiming at treating ALS,
Acquired by
Collidion Logo
Collidion
Founded
obfuscation
PrivateGrant San Diego, California, United States1-10 www.plexpharma.com
Biotechnology
Medical Device
Pharmaceutical
Overview

Plex Pharmaceuticals
Total Funding
obfuscation
Growth Score
57
Heat Score
47

Total Funding
obfuscation
obfuscation
Grant raised
obfuscation
Growth Score57
0 pts
in past quarter
Heat Score 47
4 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
See more interactive data and historical milestones on desktop for the best experience

About Plex Pharmaceuticals

CB Rank
123154
Plex Pharmaceuticals a biotechnology company aiming at treating ALS,
Acquired by
Collidion Logo
Collidion
Founded
obfuscation
PrivateGrant San Diego, California, United States1-10 www.plexpharma.com
Biotechnology
Medical Device
Pharmaceutical

Funding Rounds

Grant
OBF
in
obfuscation
Grant
OBF
in
obfuscation
Seed
OBF
in
obfuscation

Key People

Details

Legal Name Plex Pharmaceuticals, Incorporated
Operating Status Active
Company Type For Profit
Founders  G. Sridhar Prasad
About the Company
Plex's mission is to accelerate seminal academic discoveries into safe and effective treatments for unmet and under-served medical needs with a focus on neurodegenerative disorders.
Phone Number (858)587-8800
Contact Email bd@plexpharma.com
Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

Neurodegenerative Disorders Drug Discovery Programs
Programs to develop modulators of heat shock proteins and FK506 Binding Protein as treatments for neurodegenerative diseases like Parkinson’s and ALS.
Non-surgical Cataracts Treatment Development
Development of molecules that enhance alpha-crystallin chaperone activity to prevent or slow cataract formation without surgery.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 3
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Grant - Plex Pharmaceuticals Logo
Grant - Plex Pharmaceuticals
1
obfuscation
— Grant
obfuscation
Grant - Plex Pharmaceuticals Logo
Grant - Plex Pharmaceuticals
1
obfuscation
— Grant
obfuscation
Grant - Plex Pharmaceuticals Logo
Grant - Plex Pharmaceuticals
1
obfuscation
— Grant
obfuscation
Grant - Plex Pharmaceuticals Logo
Grant - Plex Pharmaceuticals
1
obfuscation
— Grant
obfuscation
Grant - Plex Pharmaceuticals Logo
Grant - Plex Pharmaceuticals
1
obfuscation
— Grant

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 3
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Grant - Plex Pharmaceuticals Logo
Grant - Plex Pharmaceuticals
1
obfuscation
— Grant
obfuscation
Grant - Plex Pharmaceuticals Logo
Grant - Plex Pharmaceuticals
1
obfuscation
— Grant
obfuscation
Grant - Plex Pharmaceuticals Logo
Grant - Plex Pharmaceuticals
1
obfuscation
— Grant
obfuscation
Grant - Plex Pharmaceuticals Logo
Grant - Plex Pharmaceuticals
1
obfuscation
— Grant
obfuscation
Grant - Plex Pharmaceuticals Logo
Grant - Plex Pharmaceuticals
1
obfuscation
— Grant

Investors

M&A Details

Plex Pharmaceuticals was acquired by Collidion on
obfuscation
.
Transaction Name 
Plex Pharmaceuticals acquired by Collidion Logo
Plex Pharmaceuticals acquired by Collidion
Acquired by 
Collidion Logo
Collidion
Announced Date 
obfuscation
Market Intelligence
People
View Profiles & Contacts
Headcount 1-10 Employee Profiles 3 Board Members and Advisors 3 Contacts 3

Employee Profiles

Board Members and Advisors

News
Technology
View Tech Report

Monthly Web Visits

115
-16.67%
 in past month

Active Website Tech Count

20Plex Pharmaceuticals is actively using 20 technologies for its website, according to BuiltWith. These include Viewport Meta, SSL by Default, and  U.S. Server Location.

Total IP

10The intellectual property of Plex Pharmaceuticals includes 10 registered patents primarily in the 'Medical Or Veterinary Science; Hygiene' category, according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is Plex Pharmaceuticals's headquarters? Plex Pharmaceuticals is located in San Diego, California, United States.Who invested in Plex Pharmaceuticals? Plex Pharmaceuticals has 2 investors including National Institutes of Health and  National Institute of Allergy and Infectious Diseases.When was the last funding round for Plex Pharmaceuticals? Plex Pharmaceuticals closed its last funding round on
obfuscation
from a Grant round.Who are Plex Pharmaceuticals's competitors? Alternatives and possible competitors to Plex Pharmaceuticals may include Amylyx Pharmaceuticals, Alzheon, and  Taysha Gene Therapies.How much funding has Plex Pharmaceuticals raised to date? Plex Pharmaceuticals has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(69c1996 1)
|